Back Stocks profile

Stock analysis tool for investors

Aarti Pharmalabs Ltd.

₹349.15 -7.40 (-2.08%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Performance

Today’s low

346.40

Today’s High

360.00

52W low

234.80

52W High

421.00

Open Price

355.60

Prev. Close

315.55

Volume

123218.00

Value

43021564.70

Fundamentals

Market Cap Cr

3164.20

Price to Earnings

0.00

Price to Book Value

2.00

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM Cr

0.00

Net Profit TTM Cr

0.00

Cash From Operating Activity Cr

0.00

Return on Equity %

12.41

EMA & SMA

Bullish Moving Averages

2

Bearish Moving Averages

9

5Day EMA Rs

353.2

10Day EMA Rs

358.5

12Day EMA Rs

360

20Day EMA Rs

361.2

26Day EMA Rs

358.8

50Day EMA Rs

345.6

ema_100

ema_200

5Day SMA Rs

350.6

10Day SMA Rs

356.9

20Day SMA Rs

374

30Day SMA Rs

369.1

50Day SMA Rs

337.1

sma_100

sma_150

sma_200

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

26 May, 2023

66.7

Week

54.7

Month

54.2

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

357.57

PIVOT

First Resistance

361.58

Second Resistance

366.62

Third Resistance

370.63

First Support

352.53

Second Support

348.52

Third Support

343.48

Relative Strength Index

45.81

Money Flow Index

32.1

MACD

1.17

MACD Signal

7.23

Average True Range

18.54

Average Directional Index

30.85

Rate of Change (21)

-3.82

Rate of Change (125)

Commodity Channel Index

-87.6

Williams %R

-84.5

BETA

1 Month

0.3

3 Month

-0.1

1 Year

3 Year

PRICE CHANGE ANALYSIS

↓ -0.96%

1 Week

Low

High

336

362.6

↓ -3.82%

1 Month

Low

High

336

421

↑ 11.12%

3 Months

Low

High

269

421

↓ %

6 Months

Low

High

234.8

421

↓ %

1 Year

Low

High

234.8

421

Indicator Mar 2023 Dec 2022 Mar 2022 Graph
Total Revenue Qtr cr 374.27 1138.26 367.21
Operating Expenses Qtr Cr 297.48 905.44 296.49
Operating Profit Qtr Cr 76.79 231.54 68.21
EBIDT Qtr Cr 76.79 232.82 70.72
Depreciation Qtr Cr 14.25 41.52 12.44
Net Profit Qtr Cr 39.99 131.73 44.88
Basic EPS Qtr Rs 4.41 14.54 4.95
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual Cr 1512.53 0.00 0.00
Operating Expenses Annual Cr 1202.91 0.08 0.00
Operating Profit Annual in Cr 308.34 -0.08 -0.00
Operating Profit Margin Annual % 20.39 -4941.51 -
Total Expenses Annual Cr 1279.17 0.08 0.00
EBIDT Annual Cr 309.62 -0.08 -0.00
EBIDT Annual margin % 20.47 -4841.51 -
Depreciation Cr 55.77 0.00 0.00
PAT Before ExtraOrdinary Items Annual Cr 171.73 -0.08 -0.00
Net Profit Annual Cr 171.73 -0.08 -0.00
Basic EPS Annual Rs 18.95 -3.09 -0.18
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual Cr 1438.58 0.15 0.23
Minority Interest Liability Annual Cr - - -
Total Non Current Liabilities Annual Cr 69.38 0.00 0.02
Total Current Liabilities Annual Cr 455.31 0.01 0.00
Total Capital Plus Liabilities Annual Cr 1963.27 0.16 0.25
Fixed Assets Annual Cr 950.30 0.00 0.00
Total Non Current Assets Annual Cr 1004.30 0.00 0.00
Total Current Assets Annual Cr 958.97 0.16 0.25
Total Assets Annual Cr 1963.27 0.16 0.25
Contingent Liabilities plus Commitments Annual Cr - 0.00 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual Cr - -0.10 0.00
Cash from Investing Activity Annual Cr - 0.00 0.00
Cash from Financing Annual Activity Cr - 0.00 0.00
Net Cash Flow Annual Cr - -0.10 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual Rs 158.75 5.98 9.07
ROE Annual % 11.93 -51.56 -2.02
ROCE Annual % 16.83 -51.45 -1.87
Total Debt to Total Equity Annual 0.14 0.00 0.00
EBDIT Annual Margin % 20.48 0.00 0.00
Indicator Mar 2023 Dec 2022 Mar 2022 Graph
Total Revenue Qtr cr 485.80 1461.74 462.82
Operating Expenses Qtr Cr 405.06 1198.11 384.68
Operating Profit Qtr Cr 80.00 262.06 75.62
EBIDT Qtr Cr 80.74 263.64 78.14
Depreciation Qtr Cr 15.95 46.59 14.07
Net Profit Qtr Cr 42.87 150.62 48.87
Basic EPS Qtr Rs 4.73 16.62 5.39
Indicator Mar 2023 Graph
Total Revenue Annual Cr 1947.55
Operating Expenses Annual Cr 1603.18
Operating Profit Annual in Cr 342.05
Operating Profit Margin Annual % 17.56
Total Expenses Annual Cr 1686.77
EBIDT Annual Cr 344.37
EBIDT Annual margin % 17.68
Depreciation Cr 62.54
PAT Before ExtraOrdinary Items Annual Cr 193.49
Net Profit Annual Cr 193.49
Basic EPS Annual Rs 21.35
Indicator Mar 2023 Graph
Total ShareHolders Funds Annual Cr 1558.48
Minority Interest Liability Annual Cr 0.00
Total Non Current Liabilities Annual Cr 80.87
Total Current Liabilities Annual Cr 591.58
Total Capital Plus Liabilities Annual Cr 2230.93
Fixed Assets Annual Cr 1025.93
Total Non Current Assets Annual Cr 1075.17
Total Current Assets Annual Cr 1155.76
Total Assets Annual Cr 2230.93
Contingent Liabilities plus Commitments Annual Cr -
Indicator Mar 2023 Graph
Cash from Operating Activity Annual Cr -
Cash from Investing Activity Annual Cr -
Cash from Financing Annual Activity Cr -
Net Cash Flow Annual Cr -
Indicator Mar 2023 Graph
Book Value Per Share Annual Rs 171.98
ROE Annual % 12.41
ROCE Annual % 17.19
Total Debt to Total Equity Annual 0.14
EBDIT Annual Margin % 17.70
Name Holding Percent Holding Id Pledged % Locked %
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund 2.11 10325949 - -
Hdfc Trustee Company Ltd - A/C Hdfc Mid - Capopportunities Fund 2.03 10325950 - -
Baron Emerging Markets Fund 1.13 10325957 - -
Name Holding Percent Holding Id Pledged % Locked %
Rashesh Chandrakant Gogri 4.23 10325895 0 0
Renil Rajendra Gogri 3.08 10325897 0 0
Mirik Rajendra Gogri 3.08 10325896 0 0
Hetal Gogri Gala 2.89 10325898 0 0
Jaya Chandrakant Gogri 2.7 10325899 0 0
Sarla Shantilal Shah 2.69 10325900 0 0
Rajendra Vallabhaji Gogri 1.57 10325901 0 0
Nehal Garewal 1.24 10325902 0 0
Nikhil Parimal Desai 0.85 10325903 0 0
Aarnav Rashesh Gogri 0.61 10325908 0 0
Aashay Rashesh Gogri 0.61 10325909 0 0
Manisha Rashesh Gogri 0.61 10325910 0 0
Bhavna Shah Lalka 0.57 10325911 0 0
Arti Rajendra Gogri 0.52 10325912 0 0
Anushakti Enterprise Private Limited 3.19 10325929 0 0
LABDHI BUSINESS TRUST (Saswat Trusteeship Private Limited) 3.14 10325930 0 0
ORCHID FAMILY TRUST (Relacion Trusteeship Services Private Limited) 1.82 10325931 0 0
TULIP FAMILY TRUST (Gloire Trusteeship Services Private Limited) 1.82 10325932 0 0
Safechem Enterprises Private Limited 1.61 10325933 0 0
MANOMAYA BUSINESS TRUST (Alabhya Trusteeship Private Limited) 1.44 10325934 0 0
Heena Family Private Trust (Barclays Wealth Trustees India Private Limited) 0.92 10325935 0 0
Bhavna Family Private Trust (Barclays Wealth Trustees India Pvt Ltd) 0.89 10325936 0 0
JASMINE FAMILY TRUST (Relacion Trusteeship Services Private Limited) 0.76 10325937 0 0
Alchemie Financial Services Limited 0.74 10325938 0 0
LOTUS FAMILY TRUST (Gloire Trusteeship Services Private Limited) 0.69 10325939 0 0
Name Holding Percent Holding Id
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund 2.11 10325949
Hdfc Trustee Company Ltd - A/C Hdfc Mid - Capopportunities Fund 2.03 10325950
Baron Emerging Markets Fund 1.13 10325957
Morgan Stanley Investment Funds Emerging Leaders Equity Fund 1.12 10325958
Life Insurance Corporation Of India 6.8 10325952
Name Holding Percent Holding Id
HUF 0.82 10325961
Unclaimed or Suspense or Escrow Account 0.65 10325962
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 12, 2023 Audited Results -
Ex-Date Bonus Ratio Record Date
Bigul
15 May 2023

Aarti Pharmalabs Ltd - 543748 - Related Party Transactions For The Half Year Ended March 31, 2023.

 Updated List of Related Party Transactions for the Half year ended March 31, 2023.
15 May 2023

AARTIPHARM Consolidated March 2023 Net Sales at Rs 485.06 crore, up 5.38% Y-o-Y
Bigul
14 May 2023

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 of SEBI Listing Regulations, we hereby enclose Newspaper Publication of Standalone & Consolidated Financial Results for the quarter and year ended March 31, 2023
Bigul
12 May 2023

Aarti Pharmalabs Ltd - 543748 - Related Party Transaction For The Half Year Ended March 31, 2023.

 Related Party Transaction for the half year ended March 31, 2023.
Bigul
12 May 2023

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 Appointment of Statutory Auditor
Bigul
12 May 2023

Aarti Pharmalabs Ltd - 543748 - Results Financial Results For March 31,2023

 Audited Financial Results (Standalone and Consolidated) for Quarter and Year Ended March 31, 2023.
Bigul
12 May 2023

Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of Board Meeting

 Outcome of Board Meeting held on May 12,2023
Bigul
03 May 2023

Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Meeting Scheduled To Be Held On Friday, May 12, 2023.

 Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2023 ,inter alia, to consider and approve - Audited Financial Results for the quarter ended March 31, 2023 and Audited Financial Statements for the year ended March 31, 2023 - Any other business matter, if required, with the permission of Chair
Bigul
24 Apr 2023

Aarti Pharmalabs Ltd - 543748 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAarti Pharmalabs Ltd 2CIN NO.U24100GJ2019PLC110964 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Nikhil Natu Designation: Company Secretary EmailId: investorrelations@aartipharmalabs.com Name of the Chief Financial Officer: Piyush Lakhani Designation: Chief Financial Officer EmailId: investorrelations@aartipharmalabs.com Date: 24/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Bigul
19 Apr 2023

Aarti Pharmalabs Ltd - 543748 - Reply To Clarification Sought With Respect To Significant Movement In Price Of Company'S Security At BSE Limited

 Reply to clarification sought with respect to significant movement in price of Company's security at BSE Limited
See all News